Gene+ Technology, providing gene testing service for cancer prevention, announced it raised RMB200 million (US$27.9 million) in a series B funding round led by Chinese private equity investment firm Co-Stone Asset Management Co., Ltd on Monday.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription?